A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Entex La Warnings, Precautions, Pregnancy, Nursing, Abuse - Guaifenesin and Phenylephrine
Entex La Warnings, Precautions, Pregnancy, Nursing, Abuse - Guaifenesin and Phenylephrine
WARNINGS
Sympathomimetic amines should be used with caution in patients
with hypertension, diabetes
mellitus, heart disease,
peripheral vascular
disease, increased intraocular
pressure, hyperthyroidism, or prostatic
hypertrophy.
PRECAUTIONS
Information for the Patient: Do not crush or chew phenylephrine
HCl w/ guaifenesin long
acting tablets prior to swallowing.
Drug/Laboratory Test Interactions: Guaifenesin has
been reported to interfere with clinical
laboratory determinations of urinary 5-hydroxyindole-acetic acid
(5-HIAA) and urinary vanillylmandelic acid
(VMA).
Pregnancy: Pregnancy Category C. Animal reproduction
studies have not been conducted with phenylephrine HCl w/guaifenesin long
acting tablets. It is also not known whether phenylephrine HCl w/guaifenesin
long acting tablets, can cause
fetal harm when administered
to a pregnant woman or can affect
reproduction capacity.
Phenylephrine HCl w/guaifenesin long acting tablets, should be given to
a pregnant woman
only if clearly needed.
Nursing Mothers: It is not known whether the drugs in phenylephrine
HCl w/guaifenesin long acting tablets, are excreted in human
milk. Because many drugs are excreted in human
milk and because of the potential
for serious adverse reactions in nursing
infants, a decision should be made whether to discontinue nursing
or to discontinue the product, taking into account the importance of the
drug to the mother.
Pediatric Use: Safety and effectiveness
of phenylephrine HCl w/guaifenesin long acting tablets, in children below
the age of 6 have not been established.
top
